Literature DB >> 22473996

MicroRNA-155 is required for Mycobacterium bovis BCG-mediated apoptosis of macrophages.

Devram Sampat Ghorpade1, Rebecca Leyland, Mariola Kurowska-Stolarska, Shripad A Patil, Kithiganahalli Narayanaswamy Balaji.   

Abstract

Pathogenic mycobacteria, including Mycobacterium tuberculosis and Mycobacterium bovis, cause significant morbidity and mortality worldwide. However, the vaccine strain Mycobacterium bovis BCG, unlike virulent strains, triggers extensive apoptosis of infected macrophages, a step necessary for the elicitation of robust protective immunity. We here demonstrate that M. bovis BCG triggers Toll-like receptor 2 (TLR2)-dependent microRNA-155 (miR-155) expression, which involves signaling cross talk among phosphatidylinositol 3-kinase (PI3K), protein kinase Cδ (PKCδ), and mitogen-activated protein kinases (MAPKs) and recruitment of NF-κB and c-ETS to miR-155 promoter. Genetic and signaling perturbations presented the evidence that miR-155 regulates PKA signaling by directly targeting a negative regulator of PKA, protein kinase inhibitor alpha (PKI-α). Enhanced activation of PKA signaling resulted in the generation of PKA C-α; phosphorylation of MSK1, cyclic AMP response element binding protein (CREB), and histone H3; and recruitment of phospho-CREB to the apoptotic gene promoters. The miR-155-triggered activation of caspase-3, BAK1, and cytochrome c translocation involved signaling integration of MAPKs and epigenetic or posttranslational modification of histones or CREB. Importantly, M. bovis BCG infection-induced apoptosis was severely compromised in macrophages derived from miR-155 knockout mice. Gain-of-function and loss-of-function studies validated the requirement of miR-155 for M. bovis BCG's ability to trigger apoptosis. Overall, M. bovis BCG-driven miR-155 dictates cell fate decisions of infected macrophages, strongly implicating a novel role for miR-155 in orchestrating cellular reprogramming during immune responses to mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22473996      PMCID: PMC3372268          DOI: 10.1128/MCB.06597-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

1.  Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.

Authors:  Catherine L Jopling; Minkyung Yi; Alissa M Lancaster; Stanley M Lemon; Peter Sarnow
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

Review 2.  MicroRNAs: regulators of gene expression and cell differentiation.

Authors:  Ramesh A Shivdasani
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

3.  MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis.

Authors:  Mathias Oertli; Daniela B Engler; Esther Kohler; Manuel Koch; Thomas F Meyer; Anne Müller
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

4.  miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1.

Authors:  Changming Lu; Xin Huang; Xiaoxiao Zhang; Kristin Roensch; Qing Cao; Keiichi I Nakayama; Bruce R Blazar; Yan Zeng; Xianzheng Zhou
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

5.  SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation.

Authors:  Yun He; Wei Zhang; Rong Zhang; Haifeng Zhang; Wang Min
Journal:  J Biol Chem       Date:  2006-01-05       Impact factor: 5.157

6.  MicroRNAs and cell differentiation in mammalian development.

Authors:  Lin Song; Rocky S Tuan
Journal:  Birth Defects Res C Embryo Today       Date:  2006-06

7.  NOTCH1 up-regulation and signaling involved in Mycobacterium bovis BCG-induced SOCS3 expression in macrophages.

Authors:  Yeddula Narayana; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

8.  MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation.

Authors:  Guisheng Song; Yuxia Zhang; Li Wang
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

9.  microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.

Authors:  Elena Vigorito; Kerry L Perks; Cei Abreu-Goodger; Sam Bunting; Zou Xiang; Susan Kohlhaas; Partha P Das; Eric A Miska; Antony Rodriguez; Allan Bradley; Kenneth G C Smith; Cristina Rada; Anton J Enright; Kai-Michael Toellner; Ian C M Maclennan; Martin Turner
Journal:  Immunity       Date:  2007-12-06       Impact factor: 31.745

10.  Requirement of bic/microRNA-155 for normal immune function.

Authors:  Antony Rodriguez; Elena Vigorito; Simon Clare; Madhuri V Warren; Philippe Couttet; Dalya R Soond; Stijn van Dongen; Russell J Grocock; Partha P Das; Eric A Miska; David Vetrie; Klaus Okkenhaug; Anton J Enright; Gordon Dougan; Martin Turner; Allan Bradley
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

View more
  55 in total

1.  MicroRNA-155 is required for clearance of Streptococcus pneumoniae from the nasopharynx.

Authors:  Chris P Verschoor; Michael G Dorrington; Kyle E Novakowski; Julie Kaiser; Katherine Radford; Parameswaran Nair; Varun Anipindi; Charu Kaushic; Michael G Surette; Dawn M E Bowdish
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  The roles of microRNAs on tuberculosis infection: meaning or myth?

Authors:  Harapan Harapan; Fitra Fitra; Ichsan Ichsan; Mulyadi Mulyadi; Paolo Miotto; Nabeeh A Hasan; Marta Calado; Daniela M Cirillo
Journal:  Tuberculosis (Edinb)       Date:  2013-08-15       Impact factor: 3.131

Review 3.  Cell death and autophagy in tuberculosis.

Authors:  Andrew H Moraco; Hardy Kornfeld
Journal:  Semin Immunol       Date:  2014-10-17       Impact factor: 11.130

4.  Sonic hedgehog-dependent induction of microRNA 31 and microRNA 150 regulates Mycobacterium bovis BCG-driven toll-like receptor 2 signaling.

Authors:  Devram Sampat Ghorpade; Sahana Holla; Srini V Kaveri; Jagadeesh Bayry; Shripad A Patil; Kithiganahalli Narayanaswamy Balaji
Journal:  Mol Cell Biol       Date:  2012-11-19       Impact factor: 4.272

5.  Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.

Authors:  Praveen Prakhar; Sahana Holla; Devram Sampat Ghorpade; Martine Gilleron; Germain Puzo; Vibha Udupa; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

Review 6.  Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals.

Authors:  Kathryn Wright; Karren Plain; Auriol Purdie; Bernadette M Saunders; Kumudika de Silva
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

7.  AAV8-mediated in vivo overexpression of miR-155 enhances the protective capacity of genetically attenuated malarial parasites.

Authors:  Franziska Hentzschel; Christiane Hammerschmidt-Kamper; Kathleen Börner; Kirsten Heiss; Bettina Knapp; Julia M Sattler; Lars Kaderali; Mirco Castoldi; Jay G Bindman; Yann Malato; Holger Willenbring; Ann-Kristin Mueller; Dirk Grimm
Journal:  Mol Ther       Date:  2014-09-05       Impact factor: 11.454

8.  MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.

Authors:  Maliheh Nazari-Jahantigh; Yuanyuan Wei; Heidi Noels; Shamima Akhtar; Zhe Zhou; Rory R Koenen; Kathrin Heyll; Felix Gremse; Fabian Kiessling; Jochen Grommes; Christian Weber; Andreas Schober
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

9.  Protein kinase inhibitor γ reciprocally regulates osteoblast and adipocyte differentiation by downregulating leukemia inhibitory factor.

Authors:  Xin Chen; Bryan S Hausman; Guangbin Luo; Guang Zhou; Shunichi Murakami; Janet Rubin; Edward M Greenfield
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

10.  MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis.

Authors:  Alissa C Rothchild; James R Sissons; Shahin Shafiani; Christopher Plaisier; Deborah Min; Dat Mai; Mark Gilchrist; Jacques Peschon; Ryan P Larson; Andreas Bergthaler; Nitin S Baliga; Kevin B Urdahl; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.